An Evaluation Of Immunocore Holdings plc ADR (NASDAQ: IMCR) Prospects

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. The stock was recently discussed on Yahoo Finance as it revealed that Immunocore presented two posters at CROI 2024.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Stocks Info

The company is listed on the NASDAQ and operates within the Biotechnology industry segment. The current market capitalization of Immunocore Holdings plc ADR is $3.16B. A total of 0.57 million shares were traded on the day, compared to an average of 496.37K shares.

In the most recent transaction, Berman David M sold 36,509 shares of IMCR for 68.59 per share on Feb 28 ’24. After the transaction, the HEAD OF R&D now owns 0 company shares. In a previous transaction on Feb 27 ’24, Berman David M sold 54,938 shares at 70.86 per share. IMCR shares that HEAD OF R&D owns now total 0.

Among the insiders who sold shares, Berman David M disposed of 28,553 shares on Feb 26 ’24 at a per-share price of $70.65. This resulted in the HEAD OF R&D holding 0 shares of IMCR after the transaction. In another insider transaction, St Leger Tina Amber sold 4,375 shares at $69.89 per share on Jan 03 ’24. Company shares held by the Chief HR Officer now total 0.

It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. In terms of 52-week highs and lows, IMCR has a high of $76.98 and a low of $42.21.

As of this writing, IMCR has an earnings estimate of -$0.36 per share for the current quarter. EPS was calculated based on a consensus of 16 estimates, with a high estimate of -$0.1 per share and a lower estimate of -$0.52. The company reported an EPS of $0.05 in the last quarter, which was 113.50% higher than expectations of -$0.37.

Balance Sheet Annually/Quarterly

An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. IMCR’s latest balance sheet shows that the firm has $237.89M in Cash & Short Term Investments as of fiscal 2021. There were $63.84M in debt and $61.18M in liabilities at the time. Its Book Value Per Share was $7.37, while its Total Shareholder’s Equity was $171.55M.

Analysts Opinion

There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for IMCR is Buy with a score of 4.82.

Most Popular

Related Posts